117 Results

People

  1. Seshan
    Seshan
  2. Barakat
    Barakat
  3. Rusch
    Rusch
  4. Aghajanian
    Aghajanian
  5. Bains
    Bains
  6. Chi
    Chi
  7. Spriggs
    Spriggs
  8. Kris
    Kris
  9. Zelefsky
    Zelefsky
  10. Flores
    Flores

Groups

  1. Biostatistics Service (117)
  2. Center for Pancreatic Cancer Research (117)
  3. Epidemiology and Biostatistics (117)
  4. Surgery (75)
  5. Department of Medicine (53)
  6. Solid Tumor Oncology Division (45)
  7. Survivorship Research (42)
  8. Gynecology Disease Management Team (40)
  9. GDMT, Surgery (29)
  10. Radiation Oncology, Department of (25)
  1. "adult"
  2. "Venkatraman Seshan"
Formats
  1. Journal Article (114)
  2. Research Letter (3)
Groups
  1. Biostatistics Service (117)
  2. Center for Pancreatic Cancer Research (117)
  3. Epidemiology and Biostatistics (117)
  4. Surgery (75)
  5. Department of Medicine (53)
  6. Solid Tumor Oncology Division (45)

More Groups

People
  1. Venkatraman Seshan (117)
  2. Richard Barakat (34)
  3. Valerie Rusch (24)
  4. Carol Aghajanian (18)
  5. Dennis Chi (17)
  6. Manjit Bains (17)

More People

Years
  1. 2023 (4)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (1)
  6. 2017 (1)

More Years

Publications
  1. Gynecologic Oncology (22)
  2. International Journal of Radiation Oncology, Biology, Physics (15)
  3. Journal of Clinical Oncology (15)
  4. Journal of Thoracic and Cardiovascular Surgery (9)
  5. Cancer (8)
  6. Annals of Thoracic Surgery (7)

More Publications

Publishers
  1. Elsevier Inc. (45)
  2. American Society of Clinical Oncology (15)
  3. Mosby Elsevier (9)
  4. Wiley Blackwell (9)
  5. Elsevier Science, Inc. (8)
  6. Lippincott Williams & Wilkins (7)

More Publishers

Results (117)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Research Letter

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G. T.; Romancik, J.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The efficacy of tixagevimab–cilgavimab prophylaxis against Omicron BA.5 variants in patients with hematological malignancies: Insights from the Leukemia and Lymphoma Society Registry
    Research Letter

    Luttwak, E.; Noy, A.; Seshan, V.; Saltzman, L. A.; Greenberger, L. M.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Novel genetic subtypes of urothelial carcinoma with differential outcomes on immune checkpoint blockade
    Journal Article

    Sarfaty, M.; Golkaram, M.; Funt, S. A.; Al-Ahmadie, H.; Kaplan, S.; Song, F.; Regazzi, A.; Makarov, V.; Kuo, F.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: An open label phase II study
    Research Letter

    Qualls, D.; Noy, A.; Straus, D.; Matasar, M.; Moskowitz, C.; Seshan, V.; Dogan, A.; Salles, G.; Younes, A.; Zelenetz, A. D.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study
    Journal Article

    Luo, L.; Shen, R.; Arora, A.; Orlow, I.; Busam, K. J.; Lezcano, C.; Lee, T. K.; Hernando, E.; Gorlov, I.; Amos, C.; more...
    Pigment Cell & Melanoma Research (2022)

    Fulltext@MSK | Save
  • TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Journal Article

    Erazo, T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Refermat, A. Y.; Asgari, Z.; Yang, X.; Da Silva Ferreira, M.; Mehta, S.; Russo, M. V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Response rates to anti-PD-1 immunotherapy in microsatellite-stable solid tumors with 10 or more mutations per megabase
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Zehir, A.; Berger, M. F.; Seshan, V. E.; Chan, T. A.; Morris, L. G. T.
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering
    Journal Article

    Arora, A.; Olshen, A. B.; Seshan, V. E.; Shen, R.
    Genome Medicine (2020)

    Fulltext@MSK | Save
  • Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save